Résumé
Variation du prix de l'action
24h
Actuel
Min
10.11
Max
11.74
Recommandations | Vente |
|---|---|
Prévisions sur 12 Mois | -22.1% downside |
Prochains Résultats | 5 nov. 2026 |
|---|
Ginkgo Bioworks Holdings Inc Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
Actualités Associées
16 oct. 2026, 23:51 UTC
Ginkgo Bioworks Holdings Inc shares are trading lower in after-market hours, reflecting broader market declines amid inflation concerns and rising borrowing costs.
Lire
15 oct. 2026, 20:08 UTC
Sharply higher after $200M offering, clinical updates; sympathy with Ginkgo.
Lire
14 oct. 2026, 23:21 UTC
Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, reflecting broader market declines driven by poor tech earnings and rising crude oil prices.
Lire
13 oct. 2026, 22:06 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading, having retraced from an earlier peak and reaching a low nearly 1.9% below Tuesday's close.
Lire
12 oct. 2026, 23:16 UTC
Ginkgo Bioworks Holdings Inc gained slightly in after-market trading, maintaining a position roughly flat since Monday's close.
Lire
10 oct. 2026, 00:01 UTC
Ginkgo Bioworks Holdings Inc is trading modestly higher in after-market hours, supported by a strong broader market backdrop and positioning above its 20-day moving average.
Lire
9 oct. 2026, 20:02 UTC
Ginkgo Bioworks joins the National Science Foundation’s X-Labs program, committing $1.5 billion in in-kind support for independent research teams.
Lire
8 oct. 2026, 23:42 UTC
Ginkgo Bioworks to provide in-kind access to its Boston lab for the National Science Foundation’s $1.5 billion X-Labs program supporting independent research teams.
Lire
7 oct. 2026, 23:51 UTC
Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, marking its third consecutive session of declines following a significant dip earlier in the day.
Lire
6 oct. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc shares fell sharply after an earlier session high, continuing a significant decline since Monday's close amid mixed social media sentiment.
Lire
5 oct. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc gains amid positive online commentary about its growth potential and connection to GPT-5, despite trading lower compared to earlier sessions.
Lire
2 oct. 2026, 20:07 UTC
Ginkgo Bioworks Holdings Inc shares fell sharply, continuing a decline from Thursday's close despite remaining above its 20-day moving average.
Lire
1 oct. 2026, 23:06 UTC
Ginkgo Bioworks Holdings Inc is trading modestly lower in after-market hours, retracing from a brief peak earlier, despite strong performance over the past month.
Lire
30 sept. 2026, 20:02 UTC
Ginkgo Bioworks is trading higher after securing a $17.5 million contract from ARPA-H and expanding its Nebula lab, now the world's largest autonomous lab.
Lire
29 sept. 2026, 23:11 UTC
Ginkgo Bioworks Holdings Inc. sees increased social media attention and gains in after-market trading, maintaining a strong upward trend above its 20-day moving average.
Lire
28 sept. 2026, 23:06 UTC
Ginkgo Bioworks Holdings Inc traded roughly flat during after-market hours, remaining well above its 20-day moving average amid broader market gains over the past month.
Lire
25 sept. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc. shares are higher as CEO highlights maturing investments in autonomous lab robotics and advancements in AI driving business momentum.
Lire
24 sept. 2026, 23:06 UTC
Ginkgo Bioworks is integrating GPT-5 into its cloud lab for protein synthesis, but shares are trading lower in after-market hours amid broader market declines.
Lire
23 sept. 2026, 23:05 UTC
Ginkgo Bioworks Holdings Inc is higher in after-market trading, gaining ground since Wednesday's close, and is over 19% above its 20-day moving average.
Lire
22 sept. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc is sharply higher on Tuesday, marking a notable break from recent upward momentum observed in prior sessions.
Lire
21 sept. 2026, 20:06 UTC
Ginkgo Bioworks Holdings Inc is advancing as the broader market remains higher, maintaining an upward trend and trading above its 20-day moving average.
Lire
18 sept. 2026, 20:06 UTC
Ginkgo Bioworks Holdings Inc is seeing modest gains, maintaining a position significantly above its 20-day moving average despite fluctuations earlier in the day.
Lire
17 sept. 2026, 20:02 UTC
Ginkgo Bioworks shares rise sharply amid notable call options trading, supported by gains in the ARK Genomic Revolution ETF, despite an earlier pullback.
Lire
16 sept. 2026, 19:26 UTC
Ginkgo Bioworks announced a partnership with Eli Lilly's TuneLab to enhance drug development efficiency, as shares fell slightly since Tuesday's close.
Lire
15 sept. 2026, 20:07 UTC
Ginkgo Bioworks shares are lower, reflecting broader market declines amid negative economic indicators and rising oil prices. Earlier, shares briefly rebounded before pulling back.
Lire
14 sept. 2026, 23:06 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market hours. The broader market faces pressure from rising crude oil prices amid supply concerns.
Lire
2 sept. 2026, 19:56 UTC
Ginkgo Bioworks is gaining traction amid social media discussions on Pfizer and Google announcements, despite a generally negative market environment.
Lire
1 sept. 2026, 23:06 UTC
Ginkgo Bioworks shares are higher in after-market trading, reaching a peak above the previous day's close. The stock remains below its 20-day moving average.
Lire
31 août 2026, 22:16 UTC
Ginkgo Bioworks Holdings Inc is trading higher in after-market hours, influenced by broader market reactions to comments on inflation and interest rate expectations.
Lire
28 août 2026, 22:02 UTC
Ginkgo Bioworks Holdings Inc shares are higher in after-market trading, continuing a recent trend of daily gains despite no specific news to explain the move.
Lire
Comparaison
Variation de prix
Ginkgo Bioworks Holdings Inc prévision
Objectif de Prix
By TipRanks
Prévisions sur 12 Mois
Moyen 8 USD -22.1%
Haut 11 USD
Bas 5 USD
Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
Note du Consensus
By TipRanks
Vente
3 ratings
0
Achat
1
Maintien
2
Vente
Basé sur 3 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
Éléments financiers
$